pursuant

BioVersys and Shionogi Enter Into Global Research Collaboration For Broad-Spectrum Non-Tuberculous Mycobacteria (NTM) Clinical Candidate

July 02, 2025 01:00 ET  | Source: BioVersys Ad hoc announcement pursuant to Art. 53 LR BASEL, Switzerland, July 02,…

1 day ago

OSE Immunotherapeutics met jour linformation sur les procdures en cours

OSE Immunotherapeutics provides an update on ongoing proceedings NANTES, France, July 2, 2025, 8 AM – OSE Immunotherapeutics SA (ISIN:…

1 day ago

WhiteHawk Completes Tender Offer for Acquisition of PHX

PHILADELPHIA--(BUSINESS WIRE)--WhiteHawk Income Corporation (together with WhiteHawk Energy, LLC and their respective subsidiaries, “WhiteHawk” or the “Company”) announced that a…

2 weeks ago

Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update

June 19, 2025 01:00 ET  | Source: Addex Therapeutics Strong cash position of CHF2.8 million at end of Q1 2025GABAB…

2 weeks ago

FOBI AI Inc. Announces Closing of the Sale of German Subsidiary

June 12, 2025 16:53 ET  | Source: Fobi AI Inc. Vancouver, BC, June 12, 2025 (GLOBE NEWSWIRE) -- FOBI AI…

3 weeks ago

Novartis Pluvicto demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer

Ad hoc announcement pursuant to Art. 53 LR At interim analysis, PSMAddition trial met its primary endpoint showing statistically significant…

1 month ago

Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]

Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE WYOST® (denosumab-bbdz) and Jubbonti® (denosumab-bbdz) are first…

1 month ago

Update on the Simplified Tender Offer and Squeeze-out on NHOA

No Conditional Price Supplement PayableTAIPEI, Taiwan--(BUSINESS WIRE)--Reference is made to the simplified tender offer (the Offer) and squeeze-out transaction completed…

1 month ago

DoorDash Announces Closing of Upsized $2.75 Billion Offering of 0% Convertible Senior Notes

Opportunistic capital raise with proceeds used to enhance strategic flexibility A portion of the proceeds used to purchase a hedge…

1 month ago